Last update 21 Nov 2024
Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms Adiposederived allogeneic mesenchymal stem cells Steminent, Allogeneic adiposederived mesenchymal stem cells Steminent Biotherapeutics, Mesenchymal stem cells Steminent + [1] |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)A Phase II, Randomized, Double-Blind, Placebo-controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal (Allogeneic Adipose-derived Mesenchymal Stem Cells) Infusion for the Treatment of PolyQ Spinocerebellar Ataxia
The Safety Study of Stemchymal® (Allogeneic Adipose-Derived Mesenchymal Stem Cells) Treating on Acute Liver Failure - An Open-Label, Single-Center Phase I Trial
A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center Study to Evaluate the Safety and Efficacy of Stemchymal® Infusion for the Treatment of Polyglutamine Spinocerebellar Ataxia
100 Clinical Results associated with Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)
Login to view more data
100 Translational Medicine associated with Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)
Login to view more data
100 Patents (Medical) associated with Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)
Login to view more data
100 Deals associated with Adipose-derived allogeneic mesenchymal stem cell therapy (Steminent Biotherapeutics)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute-On-Chronic Liver Failure | Preclinical | TW | 01 Oct 2018 | |
| Spinocerebellar Ataxias | Discovery | JP | 28 Feb 2020 | |
| Cerebellar Ataxia | Discovery | TW | 01 Sep 2015 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free